The role of CDMO companies in cancer medicine has become more prominent in recent years. These specialized firms provide support to pharma companies with everything from developing, testing, and manufacturing oncology drugs to aiding life-saving treatments into the market with higher efficiency. Given the degree of sophistication of cancer drugs, CDMO companies lend critical expertise in ensuring regulatory compliance while allowing large-scale production.

India has become the prescri...Read more

The role of CDMO companies in cancer medicine has become more prominent in recent years. These specialized firms provide support to pharma companies with everything from developing, testing, and manufacturing oncology drugs to aiding life-saving treatments into the market with higher efficiency. Given the degree of sophistication of cancer drugs, CDMO companies lend critical expertise in ensuring regulatory compliance while allowing large-scale production.

India has become the prescription drug manufacturing hub globally, and several CDMO companies in the country are making immense progress in oncology drug development. Let us discuss some of the top oncology pharma companies operating in India, along with the latest trends developing in the oncology market.

Top Indian CDMOs in Oncology

1. Pinnacle Life Science

Pinnacle Life Science, an emerging CDMO company, constitutes a comprehensive drug development and manufacturing solution with an upright care of encompassment in the field of oncology.

End-to-end services include formulation development, clinical trial support, and large-scale production of cancer drugs. So, Pinnacle Life Science is equipping itself as one of the most reliable partners, with state-of-art facilities and as per the compliance requirements, for pharmaceutical companies looking for high-quality oncology solutions.

2. Biocon Limited

Biocon shines from Bangalore as an eminent biopharmaceutical company performing steadily in the field of oncology. Biocon Biologics, being its subsidiary, is known for biosimilars, which seek to be almost identical to original biologics but affordably priced.

The company makes cutting-edge advances in oncology, issuing affordable biosimilars of trastuzumab (for breast cancer treatmentpegfilgrastim (to support chemotherapy patients